Lisa Nadal
Overview
Explore the profile of Lisa Nadal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flatz L, Wagner N, Denisjuk N, Do P, Nadal L, Puca E, et al.
J Eur Acad Dermatol Venereol
. 2024 Jul;
39(2):e147-e149.
PMID: 38959382
No abstract available.
2.
Di Nitto C, Gilardoni E, Mock J, Nadal L, Weiss T, Weller M, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839699
Interferon-gamma (IFNγ) is one of the central cytokines produced by the innate and adaptive immune systems. IFNγ directly favors tumor growth control by enhancing the immunogenicity of tumor cells, induces...
3.
Peissert F, Pluss L, Giudice A, Ongaro T, Villa A, Elsayed A, et al.
Protein Sci
. 2022 Nov;
31(12):e4486.
PMID: 36317676
Programmed cell death protein 1 (PD-1) is an immunoregulatory target which is recognized by different monoclonal antibodies, approved for the therapy of multiple types of cancer. Different anti-PD-1 antibodies display...
4.
Zana A, Galbiati A, Gilardoni E, Bocci M, Millul J, Sturm T, et al.
Clin Cancer Res
. 2022 Oct;
28(24):5440-5454.
PMID: 36215129
Purpose: Small molecule drug conjugates (SMDC) are modular anticancer prodrugs that include a tumor-targeting small organic ligand, a cleavable linker, and a potent cytotoxic agent. Most of the SMDC products...
5.
Nadal L, Peissert F, Elsayed A, Weiss T, Look T, Weller M, et al.
J Immunother Cancer
. 2022 Sep;
10(9).
PMID: 36104101
Background: In this study, we describe the generation of a fully human monoclonal antibody (named '7NP2') targeting human fibroblast activation protein (FAP), an antigen expressed in the microenvironment of different...
6.
Millul J, Bassi G, Mock J, Elsayed A, Pellegrino C, Zana A, et al.
Proc Natl Acad Sci U S A
. 2021 Apr;
118(16).
PMID: 33850024
We describe the development of OncoFAP, an ultra-high-affinity ligand of fibroblast activation protein (FAP) for targeting applications with pan-tumoral potential. OncoFAP binds to human FAP with affinity in the subnanomolar...
7.
Nadal L, Corbellari R, Villa A, Weiss T, Weller M, Neri D, et al.
MAbs
. 2020 Nov;
12(1):1836713.
PMID: 33136526
Antibody-based delivery of bioactive molecules represents a promising strategy for the improvement of cancer immunotherapy. Here, we describe the generation and characterization of R6N, a novel fully human antibody specific...
8.
Corbellari R, Nadal L, Villa A, Neri D, De Luca R
Anticancer Drugs
. 2020 Apr;
31(8):799-805.
PMID: 32304410
Antibody-cytokine fusion proteins (also called 'immunocytokines') represent an emerging class of biopharmaceutical products, which are being considered for cancer immunotherapy. When used as single agents, pro-inflammatory immunocytokines are rarely capable...